2026/0141 - Invitation to Submit Proposals Under Framework Agreement(s) 2023/0436 (Medications for the Central Nervous System), 2023/0491 (Oncological and Immunomodulatory Medications)

The tender 2026/0141 invites proposals for the procurement of various medications under several framework agreements. These agreements include 2023/0436, which pertains to medications for the central nervous system, and 2023/0491, which focuses on oncological and immunomodulatory medications. The aim of this tender is to ensure the availability of essential pharmaceuticals that meet the healthcare needs of the population. Interested parties are required to submit their proposals in accordance with the specifications outlined in the framework agreements. Key requirements include compliance with regulatory standards for pharmaceutical products, the ability to supply the medications in a timely manner, and adherence to quality assurance protocols. The location for the delivery of these medications will be specified in the tender documents. This procurement is crucial for maintaining effective healthcare services, particularly in the treatment of neurological disorders and cancer. Bidders must demonstrate their capacity to fulfill the contract requirements and provide evidence of their experience in the pharmaceutical sector. The deadline for proposal submission and further details regarding the evaluation criteria will be provided in the official tender documentation.

This is a supplies contract in the information and communication technology sector. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 232.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the information and communication technology sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.